Integrating PET/CT and correlative biomarkers for prospective evaluation of extramedullary disease in relapsed/refractory B-ALL: implications for CAR T-cell therapy.

Journal: Journal for immunotherapy of cancer •

Abstract

Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.

Subjects & Keywords

How to Cite this Article

Solter ML, Wang YJ, Li G, et al. (2026). "Integrating PET/CT and correlative biomarkers for prospective evaluation of extramedullary disease in relapsed/refractory B-ALL: implications for CAR T-cell therapy.". Journal for immunotherapy of cancer. https://doi.org/10.1136/jitc-2026-016031